Heat-stable ritonavir approved, ending treatment stranglehold for people living with HIV/AIDSread more
Make It Happen Campaign Update: UNITAID Board still discussing finer details of the Patent Pool Entity read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
U.S. health care legislation could limit access read more
MSF responds to World Health Organization’s new HIV treatment guidelines read more
MSF sends letter to EU Ministers of Health regarding antibiotic resistance read more
The content of this website is maintained by Médecins Sans Frontières, Campaign for Access to Essential Medicines, Rue de Lausanne 78, 1211 Geneva, Switzerland. If you would like to provide feedback regarding the website, please email us at: feedback.msfaccess@msf.org
The MSF Campaign for Access to Essential Medicines takes your online privacy seriously. This website is therefore run in accordance with European data protection standards.
We have technical and organisational security measures in place which protect your data from manipulation, loss, destruction or access by unauthorized individuals.
We will collect, hold and process data including passing such elements of this information on to third parties, who may be from the MSF Campaign for Access to Essential Medicines or an agent acting on our behalf, as is necessary for that purpose.
We will not use your data for any purpose other than as stated or for purposes you give us permission to use it for. We do not share data with third parties which are not affiliated with the MSF Campaign for Access to Essential Medicines without obtaining your consent first.
You have the right to free of charge access written information about the data stored by us, about its usage and – under certain circumstances – a right to the correction, blocking or deletion of this data. Furthermore, you have the right to revoke at any time and without giving reasons the permission to gather, process and use data and to see stored personal data at any time.
This form is being provided and transmitted through a safe SSL-connection. You can recognize the safe transmission by a closed lock in the status bar of your internet browser. Your data is being encrypted on the way from your computer to us and can only be read again on our server. A security certificate provided by GeoTrust (owned by Verisign) confirms the authenticity.
Indian Court Gives Boost to Access to Medicines As Latest Appeal By Bayer is Rejected
UNITAID Patent Pool: Innovative Initiative Designed to Boost Access to Medicines is Adopted
UNITAID Patent Pool: Key Developing Countries at Risk of Being Excluded
MSF Clinical Officer Olesi Ellemani Pasulani's reflections on AIDS treatment in Malawi
Living with MDR TB: 'Expert Client' Nonkululeko Mamba's Story
MDR TB Treatment in Cambodia: A Catalyst for Change